VANCOUVER, British Columbia, Aug. 2, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) (“QLT” or the “Company”) is a biotechnology company dedicated to the development and commercialization of innovative ocular therapeutics that address the unmet medical needs of patients and clinicians worldwide. The company today reported financial results for the second quarter ended June 30, 2012. Unless specified otherwise, all amounts are in U.S. dollars and in accordance with U.S. GAAP.
